Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of intravenous piperacillin/tazobactam in peritoneal dialysis-associated peritonitis
TCTR20220515001Completed
- Sponsor
- Faculty of Medicine, Prince of Songkhla University
- Start
- Apr 2021
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of piperacillin + tazobactam in peritoneal dialysis-associated peritonitis, sponsored by Faculty of Medicine, Prince of Songkhla University. Started Apr 2021; status: completed.
02
Drugs
piperacillin + tazobactam
03
Conditions
peritoneal dialysis-associated peritonitis
Beyond the preview
Go deeper on TCTR20220515001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220515001.